Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
ZURICH (Reuters) - Patients with advanced breast cancer lived significantly longer without their disease getting worse when treated with Roche's pertuzumab and Herceptin along with a type of chemotherapy, a late-stage study showed.
NEW YORK (Reuters Health) - Less-frequent mammograms for women at low risk for breast cancer can be a cost-effective way of saving lives, according to a new study that challenges current screening guidelines for the disease.
ZURICH (Reuters) - Novartis AG said a late-stage study showed its drug hope Afinitor slowed tumor growth in advanced breast cancer, helping its chances of becoming a new blockbuster treatment.
WASHINGTON (Reuters) - Medicare will continue coverage of Roche Holdings' drug Avastin for breast cancer regardless of what U.S. health regulators decide about the medicine, a spokesperson for the U.S. health insurer said.
ZURICH (Reuters) - Swiss drugmaker Roche Holding AG had nothing to lose by giving Avastin another roll of the dice, and by doing so showed the world it still believes the drug should be used in breast cancer.
SILVER SPRING, Md. (Reuters) - U.S. health advisers delivered a blow to Roche Holding on Wednesday, voting to reject the use of Roche Holding drug Avastin for breast cancer while the Swiss drugmaker conducts more studies.
CHICAGO (Reuters) - The longest-running breast cancer screening study ever conducted has shown that regular mammograms prevent deaths from breast cancer, and the number of lives saved increases over time, an international research team said on Tuesday.
SILVER SPRING, Md. (Reuters) - Breast cancer patients testified that Roche Holding AG's drug Avastin saved their lives as U.S. health officials consider whether the world's best-selling cancer drug should still be approved for that condition.
CHICAGO (Reuters) - Tailoring cancer drugs to target the molecular signature of an individual patient's tumor helps more than a scattershot approach, according to early-stage research.
NEW YORK (Reuters Health) - Women with breast cancer who take common blood pressure drugs may have better odds of surviving the disease, according to two preliminary studies.